Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rite Aid Corporation (RAD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
6.85+0.11 (+1.63%)
At close: 04:00PM EDT
6.84 -0.01 (-0.15%)
After hours: 07:38PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close6.74
Open6.67
Bid6.72 x 1800
Ask7.10 x 900
Day's Range6.42 - 7.07
52 Week Range4.68 - 19.22
Volume3,084,044
Avg. Volume4,603,339
Market Cap381.164M
Beta (5Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)-9.96
Earnings DateSep 21, 2022 - Sep 26, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 14, 1999
1y Target Est5.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RAD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rite Aid Corporation
    Analyst Report: Walgreens Boots Alliance, Inc.Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
  • Motley Fool

    Zoom Video Communications: Bull vs. Bear

    Why Rite Aid's (NYSE: RAD) stock pop and raised guidance still aren't enough to get him interested in buying shares. Additionally, with shares down nearly 70% over the past year, is Zoom Video Communications (NASDAQ: ZM) a screaming buy or past its prime? To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.

  • Yahoo Finance Video

    Walgreens earnings top estimates, sales drop 4.2%

    Yahoo Finance Live anchors discuss third-quarter earnings for Walgreens.

  • Business Wire

    Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members

    PHILADELPHIA, June 30, 2022--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually.

Advertisement
Advertisement